115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)
  7. Center for Hematologic Malignancies (13263)
  8. Hematologic Malignancies, Division of (13087)
  9. Sloan Kettering Institute Postdocs (12936)
  10. Department of Pathology and Laboratory Medicine (12615)
Formats
  1. Journal Article (66746)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3744)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39033)
  2. GSK Faculty (22468)
  3. Solid Tumor Oncology Division (22056)
  4. Surgery (21247)
  5. Sloan Kettering Institute Faculty (16086)
  6. Survivorship Research (15762)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1050)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of nirogacestat on pain, a key symptom in patients with desmoid tumors (DT): Results from the phase 3 DeFi study
    Meeting Abstract

    Van Der Graaf, W. T. A.; Gounder, M. M.; Ratan, R.; Ivanescu, C.; Marcus, J.; Bell, T.; Lim, A.; Smith, L. M.; Oton, A. B.; Alcindor, T.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients (pts) with solid tumors: Safety and efficacy in patients with dedifferentiated liposarcoma (DDLPS)
    Meeting Abstract

    LoRusso, P.; Gounder, M. M.; Yamamoto, N.; Patel, M. R.; Bauer, T. M.; Geng, J.; Sailer, R.; Tang, Y.; Jayadeva, G.; Schöffski, P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • ETCTN/NCI 10330: A phase 2 study of belinostat with SGI-110 (guadecitabine) or ASTX727 (decitabine/cedazuridine) for the treatment of unresectable and metastatic conventional chondrosarcoma
    Meeting Abstract

    Lacuna, K. P.; Lee, S. M.; Ge, L.; Druta, M.; Conley, A. P.; Keohan, M. L.; Agulnik, M.; Burgess, M. A.; Chalmers, A. W.; D'Amato, G. Z.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics (PK), and clinical activity of bezuclastinib + sunitinib in previously-treated gastrointestinal stromal tumor (GIST): Results from part 1 of the phase 3 Peak study
    Meeting Abstract

    Tap, W. D.; Wagner, A. J.; Bauer, S.; Heinrich, M. C.; Jones, R. L.; Serrano, C.; von Mehren, M.; Somaiah, N.; Andor, T.; Zou, L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma
    Meeting Abstract

    Tap, William D.; Cote, Gregory Michael; Burris, Howard A.; Gore, Lia; Beeram, Muralidhar; Conley, Anthony Paul; Gianolio, Diego A.; Qu, Zhe; Gliser, Camelia; Pandya, Shuchi Sumant; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • RINGSIDE phase 2/3 trial of AL102 for treatment of desmoid tumors (DT): Phase 2 results
    Meeting Abstract

    Gounder, M. M.; Jones, R. L.; Chugh, R.; Agulnik, M.; Singh, A. S.; Van Tine, B. A.; Andelkovic, V.; Choy, E.; Lewin, J. H.; Ratan, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tumor volume and T2 hyperintensity changes from DeFi: A phase 3, randomized, controlled trial of nirogacestat in patients with desmoid tumors
    Meeting Abstract

    Alcindor, T.; Kasper, B.; Gounder, M. M.; Ratan, R.; Van Der Graaf, W. T. A.; Wilky, B. A.; Riedel, R. F.; Federman, N.; Peruzzi, A.; Moody, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety and clinical activity of TTI-621 in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcoma: Results from the low-dose expansion cohort
    Meeting Abstract

    Movva, S.; Druta, M.; Davis, L. E.; Monga, V.; Milhem, M. M.; Bailey, H. H.; Chugh, R.; Bruns, I.; Allgood, V. E.; Chawla, S. P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save